Pharmaceutical suspensions of ursodeoxycholic acid for pediatric patients: in vitro and in vivo studies-Reference-Cited by-同舟云学术

Pharmaceutical suspensions of ursodeoxycholic acid for pediatric patients: in vitro and in vivo studies

Published:2021-04-06 Issue:5 Volume:26 Page:599-609
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Boscolo Oriana¹,Salvo Leandro¹,Dobrecky Cecilia¹,Fissore Eliana N.²³,Buontempo Fabian¹⁴,Tripodi Valeria¹³,Lucangioli Silvia E.¹³

Affiliation:

1. Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina

2. Departamento de Industrias, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, ITAPROQ-UBA-CONICET, Buenos Aires, Argentina

3. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina

4. Servicio de Farmacia. Hospital de Pediatría Prof. Dr Juan Patricio. Garrahan, Buenos Aires, Argentina

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2021.1905662

Reference49 articles.

1. Allergan. 2014. “URSO”and “URDO DS” tablets. Canada: Aptalis Pharma Canada Inc; [Accessed April 25, 2020]. https://allergan-web-cdnprod.azureedge.net/allergancanadaspecialty/allergancanadaspecialty/media/actavis-canada-specialty/en/products/pms/urso_urso-ds-pm_english_18aug2014.pdf.

2. Formulations for children: problems and solutions

3. Xanthan hydrogel films: Molecular conformation, charge density and protein carriers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability of compounded preparations – A Romanian pediatric hospital perspective;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

2. Formulation and Characterization of Ursodeoxycholic Acid Nanosuspension Based on Bottom-Up Technology and Box–Behnken Design Optimization;Pharmaceutics;2023-07-28

3. Dissolution testing of ursodeoxycholic acid suspension using SPE as sample preparation;RPS Pharmacy and Pharmacology Reports;2022-12-01